TürkiyeHealth policy
Turkish Society for Rheumatology publishes first national diagnosis and treatment recommendations for Takayasu arteritis
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
The Takayasu working group of the Turkish Society for Rheumatology published the first national recommendations. The document contains 40 recommendations on diagnosis, follow-up, drug treatment, pregnancy and surgery. Conventional immunosuppressive drugs are recommended as the first treatment. If the disease still comes back, TNF inhibitors or tocilizumab may be considered. According to the authors, most of the evidence is based on small numbers of patients.
What does it mean for patients and families?
The recommendations can help doctors in Türkiye follow a similar approach with patients. Which drug to choose is the rheumatologist's decision for each patient.
Source
Scientific paper: Turkish Society for Rheumatology (Turkish Takayasu Arteritis Study Group) recommendations for the diagnosis, follow-up and the treatment of Takayasu's arteritis. Clinical and Experimental Rheumatology, 2025. DOI: 10.55563/clinexprheumatol/lptjx1 · PubMed 40658482
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Takayasu arteritis
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.